Artwork

Contenido proporcionado por Buchanan Ingersoll & Rooney and Buchanan Ingersoll. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Buchanan Ingersoll & Rooney and Buchanan Ingersoll o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Francesco Tallarico, Covis Pharma

28:26
 
Compartir
 

Manage episode 289492666 series 2259216
Contenido proporcionado por Buchanan Ingersoll & Rooney and Buchanan Ingersoll. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Buchanan Ingersoll & Rooney and Buchanan Ingersoll o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode of the Legal Innovators Interview Series, hosts Ed Allera and Matthew Fedowitz of Buchanan Ingersoll and Rooney talk with Francesco Tallarico, General Counsel at Covis Pharma, a major player in the pharmaceutical space. Covis offers a portfolio of pharmaceutical products providing patients with affordable and therapeutically equivalent medications of select brands.

Ed, Matt and Francesco discuss the world of pharmaceutical approvals not just in the U.S., but around the globe and the legal hurdles that come with that. In perhaps the most highly regulated industry, general counsels face numerous challenges, and Francesco shares his insights on how he's been able to navigate them.

To learn more about Covis Pharma, visit: https://www.covispharma.com/.

To learn more about Ed Allera, visit: https://www.bipc.com/edward-allera.

To learn more about Matthew Fedowitz, visit: https://www.bipc.com/matthew-l.-fedowitz.

And to learn more about Buchanan Ingersoll & Rooney, visit: www.BIPC.com.

  continue reading

14 episodios

Artwork
iconCompartir
 
Manage episode 289492666 series 2259216
Contenido proporcionado por Buchanan Ingersoll & Rooney and Buchanan Ingersoll. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Buchanan Ingersoll & Rooney and Buchanan Ingersoll o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode of the Legal Innovators Interview Series, hosts Ed Allera and Matthew Fedowitz of Buchanan Ingersoll and Rooney talk with Francesco Tallarico, General Counsel at Covis Pharma, a major player in the pharmaceutical space. Covis offers a portfolio of pharmaceutical products providing patients with affordable and therapeutically equivalent medications of select brands.

Ed, Matt and Francesco discuss the world of pharmaceutical approvals not just in the U.S., but around the globe and the legal hurdles that come with that. In perhaps the most highly regulated industry, general counsels face numerous challenges, and Francesco shares his insights on how he's been able to navigate them.

To learn more about Covis Pharma, visit: https://www.covispharma.com/.

To learn more about Ed Allera, visit: https://www.bipc.com/edward-allera.

To learn more about Matthew Fedowitz, visit: https://www.bipc.com/matthew-l.-fedowitz.

And to learn more about Buchanan Ingersoll & Rooney, visit: www.BIPC.com.

  continue reading

14 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida